Leaflet YONISTIB 50mg film-coated tablets
- Product code:
- W61108001
- Quantity:
- 28
- Indicated for:
- prostate cancer
- Route of administration:
- oral
- Substance:
- bicalutamide (antiandrogen)
- ATC
- L02BB03 — Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-androgens
Bicalutamide is an antiandrogen medication primarily used for the treatment of advanced prostate cancer. It works by blocking androgen receptors, thereby reducing the effects of male hormones (testosterone) on prostate cancer cells. It is often used in combination with other therapies, such as gonadotropin-releasing hormone (GnRH) analogs.
Bicalutamide is taken orally, usually once daily, and is well-tolerated by most patients. Common side effects include hot flashes, breast tenderness or enlargement (gynecomastia), fatigue, and nausea. In rare cases, it may affect liver function, so regular liver monitoring is recommended.
The medication is contraindicated in women, especially during pregnancy or breastfeeding, and is not recommended for use in children. It is important for patients to strictly follow their doctor’s instructions and not discontinue treatment without medical advice.
Bicalutamide is taken orally, usually once daily, and is well-tolerated by most patients. Common side effects include hot flashes, breast tenderness or enlargement (gynecomastia), fatigue, and nausea. In rare cases, it may affect liver function, so regular liver monitoring is recommended.
The medication is contraindicated in women, especially during pregnancy or breastfeeding, and is not recommended for use in children. It is important for patients to strictly follow their doctor’s instructions and not discontinue treatment without medical advice.
General data about YONISTIB 50mg
- Substance:
- bicalutamide
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W61108001
- Concentration:
- 50mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 28
- Product type:
- Generic medicine
- Price:
- 101.80 RON
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Concentrations available for bicalutamide
- 150mg
- 50mg